MedTrace Logo

CardioMEMS HF System OUS Post Market Study

NCT02954341 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 321

Last updated 2025-02-24

Study results available
· View outcomes & findings →

Summary

The purpose of this Post Market Study (PMS) is to evaluate the use of the CardioMEMS HF System in patients with New York Heart Association (NYHA) Class III Heart Failure in a commercial setting.

Conditions

  • Heart Failure
  • Left-Sided Heart Failure
  • Congestive Heart Failure

Interventions

DEVICE

CardioMEMS HF System

Sponsors & Collaborators

  • Abbott Medical Devices

    lead INDUSTRY

Principal Investigators

  • Pascal De Groote, MD · CHU de Lille - Institut Coeur Poumon

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-07-31
Primary Completion
2023-12-08
Completion
2023-12-08

Countries

  • Australia
  • Belgium
  • Denmark
  • France
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02954341 on ClinicalTrials.gov